Zevra Therapeutics, Inc. (ZVRA)
11.66
-0.21
(-1.77%)
USD |
NASDAQ |
Aug 24, 16:00
11.66
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Total Liabilities (Quarterly) : 85.06M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 85.06M |
| March 31, 2026 | 72.78M |
| December 31, 2025 | 130.07M |
| September 30, 2025 | 136.95M |
| June 30, 2025 | 139.05M |
| March 31, 2025 | 131.68M |
| December 31, 2024 | 138.46M |
| September 30, 2024 | 121.78M |
| June 30, 2024 | 111.93M |
| March 31, 2024 | 102.46M |
| December 31, 2023 | 110.46M |
| September 30, 2023 | 71.51M |
| June 30, 2023 | 37.02M |
| March 31, 2023 | 35.19M |
| December 31, 2022 | 40.22M |
| September 30, 2022 | 25.76M |
| June 30, 2022 | 25.02M |
| March 31, 2022 | 4.207M |
| December 31, 2021 | 5.823M |
| September 30, 2021 | 5.449M |
| June 30, 2021 | 8.134M |
| March 31, 2021 | 6.184M |
| December 31, 2020 | 77.62M |
| September 30, 2020 | 73.53M |
| Date | Value |
|---|---|
| June 30, 2020 | 75.19M |
| March 31, 2020 | 77.56M |
| December 31, 2019 | 84.96M |
| September 30, 2019 | 83.51M |
| June 30, 2019 | 94.56M |
| March 31, 2019 | 94.70M |
| December 31, 2018 | 93.31M |
| September 30, 2018 | 114.08M |
| June 30, 2018 | 117.54M |
| March 31, 2018 | 122.33M |
| December 31, 2017 | 109.97M |
| September 30, 2017 | 107.41M |
| June 30, 2017 | 108.32M |
| March 31, 2017 | 109.57M |
| December 31, 2016 | 103.58M |
| September 30, 2016 | 104.35M |
| June 30, 2016 | 104.30M |
| March 31, 2016 | 123.42M |
| December 31, 2015 | 65.84M |
| September 30, 2015 | 67.16M |
| June 30, 2015 | 63.08M |
| March 31, 2015 | 40.26M |
| December 31, 2014 | 38.02M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Innoviva, Inc. | 469.46M |
| Collegium Pharmaceutical, Inc. | 1.824B |
| Johnson & Johnson | 116.09B |
| Ligand Pharmaceuticals, Inc. | 1.218B |
| Harrow, Inc. | 401.97M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 302.71M |
| Shareholders Equity (Quarterly) | 217.65M |
| Debt to Equity Ratio | 0.0069 |
| Current Ratio | 5.167 |
| Net Debt Paydown Yield | 1.42% |